Neurocrine Biosciences (NBIX) market cap

Market cap today
$16.79B

Neurocrine Biosciences (NBIX) has a market cap of $16.79B. At the end of fiscal 2025 (December 31, 2025) its market cap was $14.54B. That is 2.7% higher than the $14.16B of fiscal 2024. Today's figure is 15.5% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$16.79B
Market cap, fiscal 2025
$14.54B
Change on fiscal 2024
+2.7%
Growth, 5 years
+9.2% a year
Growth, 10 years
+11.8% a year
Highest on record
$14.54Bfiscal 2025
Lowest on record
$106.45Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Neurocrine Biosciences market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 9.2% a year; over ten years the rate was 11.8% a year. Across the 17 fiscal year-ends on record (2009–2025), the highest was $14.54B in fiscal 2025 and the lowest $106.45M in fiscal 2009.

History · 17 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Neurocrine Biosciences market cap, year by year

Neurocrine Biosciences (NBIX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$16.79B—$165.92—
2025$14.54B 2.7% up$141.83102.50M
2024$14.16B 6.4% up$136.50103.70M
2023$13.31B 12.7% up$131.76101.00M
2022$11.81B 41.7% up$119.4498.90M
2021$8.34B 11.1% down$85.1797.90M
2020$9.37B 8.9% down$95.8597.80M
2019$10.29B 51.0% up$107.4995.70M
2018$6.81B 0.3% down$71.4195.40M
2017$6.83B 103.7% up$77.5988.09M
2016$3.36B 29.8% down$38.7086.71M
2015$4.78B 186.9% up$56.5784.50M
2014$1.67B 166.3% up$22.3474.58M
2013$625.68M 24.9% up$9.3466.99M
2012$500.76M 4.6% up$7.4866.95M
2011$478.95M 18.7% up$8.5056.35M
2010$403.54M 279.1% up$7.6452.82M
2009$106.45M—$2.7239.14M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Neurocrine Biosciences and comparable companies
CompanyMarket cap
Revvity RVTY$16.50B
Exelixis EXEL$16.71B
Charles River Laboratories International CRL$15.92B
Neurocrine Biosciences NBIX$16.79B
Ascendis Pharma ASND$17.79B
ICON ICLR$14.61B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on NBIX

Neurocrine Biosciences, figure by figure

Neurocrine Biosciences (NBIX) overview: price, valuation and scorecardAll health care companies by market value

Neurocrine Biosciences market cap: questions and answers

What is Neurocrine Biosciences's market cap?

Neurocrine Biosciences (NBIX) has a market cap of $16.79B. At the end of fiscal 2025 (December 31, 2025) its market cap was $14.54B. That is 2.7% higher than the $14.16B of fiscal 2024.

What is the growth rate of Neurocrine Biosciences's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 9.2% a year; over ten years the rate was 11.8% a year.

What are the highest and lowest market cap figures on record for Neurocrine Biosciences?

Across the 17 fiscal year-ends on record (2009–2025), the highest was $14.54B in fiscal 2025 and the lowest $106.45M in fiscal 2009.

How is Neurocrine Biosciences's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Neurocrine Biosciences it is on record here for 17 fiscal years, 2009 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Neurocrine Biosciences (NBIX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/NBIX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.